Time
Room |
Session |
|
08.45 -
10.45
Erasme
with ESHG
|
Plenary
Session PS 3: Genetic testing in minors (together
with ESHG)
Chair: D. Donnai and G. Evers-Kiebooms
PS07: From 12 years of neonatal CF
testing in Brittany to the 2002 national French programme
(20')
C. Ferec (Brest)
PS08: Lessons from the Newborn
Screening Programme in Wales (20')
A. Clarke (Cardiff)
PS09: Predictive testing in minors
(30')
A. M. Codori,
K. L. Zawacki, G. M. Petersen, D. L. Miglioretti, J. A. Bacon, J.
D. Trimbath, S. V. Booker, K. Picarello, F. M. Giardiello, A. M.
Codori;
Johns Hopkins Hospital, Baltimore, MD
PS10: Carrier Testing in Childhood:
Conflict or Compromise? (30')
C. Barnes;
Genetics Centre, Guy's & St. Thomas' Hospital Trust, London,
UNITED KINGDOM
General Panel Discussion
(20')
|
10.45
-
11.15 |
Coffee/Poster
viewing/Exhibition |
11.15
-
12.30
Gutenberg |
Concurrent
Sessions
E-C 1
Screening Issues
Chair: T. Marteau
E-C01. Attitudes of Dutch general
practitioners, pediatricians and gynecologists towards cystic
fibrosis carrier screening (15')
M. J. H. Baars, L. Henneman, M. C. Cornel, L. P. Ten Kate;
VU University Medical Center, Amsterdam, NETHERLANDS.
E-C02. Feasibility and
acceptability of two screening strategies for haemochromatosis,
report of phase one of a randomised controlled trial.
(15')
C. Patch1, P. Roderick1, W. Rosenberg2;
1Health Care Research Unit, University of Southampton,
Southampton, UNITED KINGDOM, 2Division of Inflammation,
Infection and Repair, University of Southampton, Southampton,
UNITED KINGDOM.
E-C03. Coping strategies of
pregnant women after "triple-diagnostic" and those of
their partners (15')
S. Jahn, F. R. Kreuz;
Technical University, Dresden, GERMANY.
E-C04. Serum screening uptake
and attitudes towards Down's syndrome (15')
L. D. Bryant, J. M. Green, J. Hewison;
University of Leeds, Leeds, UNITED KINGDOM.
|
11.15
-
12.30
Kléber |
E-C
2 Cultural and Ethical Issues
Chair: G. Wolff
E-C05. Thalassaemia carrier
testing in pregnant Pakistani women: perceptions of ‘information’
and ‘consent’.
(15')
S. Ahmed,
J. Green, J. Hewison;
University of Leeds, Leeds, UNITED KINGDOM.
E-C06. Breast cancer: South
Asian patient's experience, attitudes, beliefs and perception of
risk. (15')
G. A. Karbani;
Centre for Research in Primary Care, Leeds, UNITED KINGDOM.
E-C06. Genetic Testing for
Hearing Impairment- Different Motivations for the Same Outcome
(15')
M. Sagi1,
O. Dagan2, H. Hochner1, H. Levi3,
A. Raas-Rothschild1, T. Cohen1;
1Department of Human Genetics Hadassah Hebrew
University Hospital, Jerusalem, ISRAEL, 2Department of
Human Genetics and Molecular Medicine, Sackler School of Medicine,
Tel-Aviv University, Tel-Aviv, ISRAEL, 3Speech and
Hearing Center, Hadassah Hebrew University Hospital, Jerusalem,
ISRAEL.
E-C08. Uses of the body and
informed consent for participants in predictive medicine research
(15')
P. Ducournau;
INSERM U558, Toulouse, FRANCE.
E-C09. Am I My Brother’s
Keeper?: Outlining Rights and Responsibilities in the Context of
the Human Genome Diversity Project
(15')
J. K. Brewer1,2;
1Harvard University, Cambridge, MA, 2De Paul
College of Law, Chicago, IL.
|
12.30
-
14.30 |
Poster Viewing/
Lunch |
14.30
-
16.00
Gutenberg |
E-C
3 Psychological Support, Family Issues and Impact of Genetic
Disease
Chair: E.
Sikkens
E-C10. A Pilot Project on
Rehabilitation in Huntington's Disease: Three Years Experience in
Italy. (15')
P. Zinzi1,
G. Jacopini1, R. De Grandis2, G. Graziani2,
S. Maceroni2, P. Zappata2, A. Bentivoglio3,
M. Frontali4;
1Institute of Psychology C.N.R., Rome, ITALY, 2Home
Care "Nova Salus", Trasacco, ITALY, 3Institute
of Neurology UCSC, Rome, ITALY, 4Institute of
Neurobiology and Molecular Medicine C.N.R., Rome, ITALY.
E-C11. Communication with
relatives about predictive genetic testing for cancer
predisposition (15')
C. Foster1,
M. Watson2, C. Moynihan1, A. Ardern-Jones2,
R. Eeles2;
1The Institute of Cancer Research, Sutton, UNITED
KINGDOM, 2Royal Marsden NHS Trust, London/Sutton,
UNITED KINGDOM.
E-C12. Myotonic Dystrophy and
the marital relationship (15')
A. Rotteveel,
A. R. Wintzen, A. Tibben;
Leids Universitair Medisch Centrum, Leiden, NETHERLANDS.
E-C13. Putting HD into words:
exploring the virtual narratives of the Italian HD support group
online. (15')
G. Jacopini1,
P. Zinzi1, A. Cordi2;
1Institute of Psychology C.N.R., Rome, ITALY, 2A.I.C.H.-ROME,
Rome, ITALY.
E-C14. Adult Survivors of
child sex abuse in the genetic counselling consultation
(15')
C. A. Falconer;
St James University Hospital, Leeds, UNITED KINGDOM.
|
14.30
-
16.00
Kléber |
E-C4
Genetic Counselling for Hereditary Cancers
Chair: M. Decruyenaere
E-C15. Women at increased risk
for breast cancer (BC) attending a regular surveillance program.
Preliminary results of the baseline measurement. (15')
S. van Dooren1,
C. Seynaeve2, H. J. Duivenvoorden1, M.
Kriege2, A. J. Rijnsburger3, J. G. M. Klijn2,
C. C. M. Bartels2, H. J. de Koning3, A.
Tibben1;
1Department of Medical Psychology and Psychotherapy,
Erasmus Medical Centre, Rotterdam, NETHERLANDS, 2Family
Cancer Clinic/Daniel den Hoed Clinic, Erasmus Medical Centre,
Rotterdam, NETHERLANDS, 3Department of Public Health,
Erasmus Medical Centre, Rotterdam, NETHERLANDS.
E-C16. The meaning of risk:
Women's perceptions of the genetic risk of breast and ovarian
cancer following BRCA1/2 mutation searching (15')
N. Hallowell1,
C. Foster1, R. Eeles1, A. Ardern Jones2,
V. Murday3, R. Houlston1, M. Watson4;
1Institute of Cancer Research, London, UNITED KINGDOM, 2Royal
Marsden Hospital, London, UNITED KINGDOM, 3St George's
Hospital, London, UNITED KINGDOM, 4The Royal Marsden
Hospital, London, UNITED KINGDOM.
E-C17. Women from HBOC
families during the BRCA genetic testing process : lay and
providers interactions (15')
C. M. Julian-Reynier1,
C. Cypowyj1, F. Chabal1, F. Eisinger2,
H. Sobol3;
1INSERM U379, Marseilles, FRANCE, 2INSERM
U379 & E9939 & Institut Paoli-Calmettes, Marseilles,
FRANCE, 3INSERM E9939 & Institut Paoli-Calmettes,
Marseilles, FRANCE.
E-C18. Theory of Engagement: A
model for predictive test counselling (15')
M. McAllister1,
A. Silver2, G. Evans3;
1Regional Genetics Service and Academic Group of
Medical Genetics, Manchester, UNITED KINGDOM, 2Oxford
Regional Genetics, Oxford, UNITED KINGDOM, 3Regional
Genetics Service and Academic Group of Medical Genetics, St Mary's
Hospital, Manchester, UNITED KINGDOM.
E-C19. Impact of predictive
genetic testing for hereditary non-polyposis colorectal cancer
(HNPCC) (15')
J. L. Halliday1,
B. Meiser2, R. Warren1, V. R. Collins1,
C. Gaff3;
1Murdoch Childrens Research Institute, Victoria,
AUSTRALIA, 2Prince of Wales Hospital, Randwick,
AUSTRALIA, 3Genetic Health Services, Victoria,
AUSTRALIA.
E-C20. The influence of
consultants’ communication and information-giving behaviours on
patient outcomes: A multi centre study of genetic counselling with
women from high risk breast cancer families
(15')
E. A. Lobb1,
P. N. Butow1, B. Meiser2, A. Barratt3,
C. Gaff4,5, M. A. Young6, E. Haan7,
G. Southers7, M. Gattas8, K. Tucker9;
1Medical Psychology Research Unit, Department of
Psychological Medicine, University of Sydney, Sydney, AUSTRALIA, 2Dept.
of Psychological Medicine, Royal North Shore Hospital, St.
Leonards, AUSTRALIA, 3Dept. of Public Health and
Community Medicine, University of Sydney, Sydney, AUSTRALIA, 4Genetic
Health Services Victoria, Royal Children’s Hospital, Parkville,
AUSTRALIA, 5Royal Melbourne Hospital, Parkville,
AUSTRALIA, 6Peter Mac Callum Cancer Institute,
Melbourne, AUSTRALIA, 7South Australian Clinical
Genetics Service, Women’s & Children’s Hospital, North
Adelaide, AUSTRALIA, 8Queensland Clinical Genetics
Service, Royal Children’s Hospital, Queensland, AUSTRALIA, 9Hereditary
Cancer Clinic, Prince of Wales Hospital, Sydney, AUSTRALIA.
|
16.30
-
18.00
Schumann
with ESHG |
Concurrent
Symposia
S 1
Cognition and Behaviour (together
with ESHG)
Chair: D. Craufurd, D. Toniolo
S01. The study of behavioural
phenotypes: implications for practice and management
(30')
A. Swillen, J. P. Fryns;
Center for Human Genetics, University Hospital Gasthuisberg,
Leuven, BELGIUM.
S02. The tortuous path from
genotype to phenotype: genes and cognition in mutant mice (30')
H. P. Lipp;
Institute of Anatomy, University of Zurich, Zurich, SWITZERLAND
S03. Fragile X Syndrome - its
impact on families (30')
B. Carmichael;
Genetic Nurse Specialist, Southend Hospital, Westcliff on Sea,
UNITED KINGDOM
|
16.30
-
18.00
Gutenberg |
Workshop
E-W 1
"How broad are the patient's shoulders?
A different way of looking at patients and their questions in the
intake session.
Organisers: B.A.W.Rozendal and H.G. van Spijker
|
| 19.30 |
Social
Evening - Dinner Cruise |
|